Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
390 Leser
Artikel bewerten:
(2)

Vantage UK receives "Best CFD Broker, Global" Award for 2024

Finanznachrichten News

LONDON, Feb. 29, 2024 /PRNewswire/ -- Vantage Markets ("Vantage") is honoured to receive the prestigious "Best CFD Broker, Global" award at the Global Brand Awards 2024. This accolade is an affirmation of Vantage's efforts and commitment to excellence and innovation in the Contracts for Difference (CFD) trading industry.

Vantage UK receives

Global Brands Magazine (GBM) is a leading publication known for its news articles and opinion pieces on well-known brands around the globe. Headquartered in the UK, it hosts a series of awards recognising outstanding companies in various industries.

The Global Brand Awards 2024, now in 12th year, celebrates excellence across industries like forex and fintech. Vantage was previously awarded "Best Affiliate Program - Global" and "Best Forex Affiliate Program - Global" in 2023, recognising the strides the company has made in growing its partnership program.

"We would like to extend our sincere appreciation to Global Brands Magazine for their ongoing recognition," says David Shayer, CEO, Vantage UK. "This award not only reflects our company's dedication but also the hard work, passion, and unwavering commitment of our exceptional Vantage team. Without their dedication, this achievement would not have been possible."

Vantage has remained at the forefront of innovation, introducing several initiatives to enhance clients' trading experience in recent months, including the launch of its brand video "Reborn a Trader" to address the biggest challenges facing CFD traders today.

As the global financial markets evolve, Vantage remains steadfast in staying ahead of industry trends and meeting its clients' evolving needs. Shayer says, "Our valued clients remain our greatest motivation. Your trust and support has been instrumental in our success, and we are grateful for the opportunity to serve you and provide the highest quality CFD trading experience."

About Vantage

Vantage (or Vantage Markets) is a multi-asset broker offering clients access to a nimble and powerful service for trading Contracts for Difference (CFDs) on Forex, Commodities, Indices, Shares, ETFs, and Bonds.

With over 13 years of market experience, Vantage transcends the role of broker, providing a trusted trading ecosystem, an award-winning mobile trading app, and a user-friendly trading platform that empowers clients to seize trading opportunities.

trade smarter @vantage

https://www.vantagemarkets.co.uk/

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 72.93% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trading derivatives is risky. It isn't suitable for everyone and, in the case of Professional clients, you could lose substantially more than your initial investment. You don't own or have rights in the underlying assets. Past performance is no indication of future performance and tax laws are subject to change. The information in this website is general in nature and doesn't take into account your or your client's personal objectives, financial circumstances, or needs. Please read our legal documents and ensure you fully understand the risks before you make any trading decisions. We encourage you to seek independent advice.

Telephone calls and online chat conversations may be recorded and monitored. Any views, opinions, technical market information or commentary published on the website are necessarily of a general educational nature only and do not constitute, and should not be considered as, investment advice as they do not take into account any individual client's investment objectives, financial resources or attitude to risk.

Regional Restrictions:

We do not offer our services to residents of certain jurisdictions such as Canada, China, Romania, Singapore, the United States and to jurisdictions on the FATF and EU/UN sanctions lists. For more information please refer to our FAQ page.

The information on this site and the products and services offered are not intended for distribution to any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

Vantage Global Prime LLP trading under Vantage, is authorised and regulated by the Financial Conduct Authority. FRN: 590299 and its principal place of business is at 7 Bell Yard, London WC2A 2JR, UK.


Photo - https://mma.prnewswire.com/media/2351143/Vantage_UK_receives__Best_CFD_Broker_Global__Award_2024.jpg

Logo - https://mma.prnewswire.com/media/1745281/Vantage_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/vantage-uk-receives-best-cfd-broker-global-award-for-2024-302075495.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.